3-phenyllactic acid has been researched along with Prostatic Hyperplasia in 1 studies
3-phenyllactic acid: alpha-hydroxy analog of phenylalanine; RN given refers to cpd without isomeric designation
3-phenyllactic acid : A 2-hydroxy monocarboxylic acid that is lactic acid in which one of the methyl hydrogens is substituted by a phenyl group.
Prostatic Hyperplasia: Increase in constituent cells in the PROSTATE, leading to enlargement of the organ (hypertrophy) and adverse impact on the lower urinary tract function. This can be caused by increased rate of cell proliferation, reduced rate of cell death, or both.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| He, J | 1 |
| Han, Z | 1 |
| Luo, W | 1 |
| Shen, J | 1 |
| Xie, F | 1 |
| Liao, L | 1 |
| Zou, G | 1 |
| Luo, X | 1 |
| Guo, Z | 1 |
| Li, Y | 1 |
| Li, J | 1 |
| Chen, H | 1 |
1 other study available for 3-phenyllactic acid and Prostatic Hyperplasia
| Article | Year |
|---|---|
Serum organic acid metabolites can be used as potential biomarkers to identify prostatitis, benign prostatic hyperplasia, and prostate cancer.
Topics: Biomarkers; Humans; Male; Meglutol; Prostate-Specific Antigen; Prostatic Hyperplasia; Prostatic Neop | 2022 |